Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set

PURPOSE: We previously validated disease-free survival (DFS) as a surrogate for overall survival (OS) in fluorouracil-based adjuvant colon cancer clinical trials. New therapies have extended survival after recurrence from 1 to approximately 2 years. We examined the possible impact of this improvemen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: de Gramont, Aimery, Hubbard, Joleen, Shi, Qian, O'Connell, Michael J., Buyse, Marc, Benedetti, Jacqueline, Bot, Brian, O'Callaghan, Chris, Yothers, Greg, Goldberg, Richard M., Blanke, Charles D., Benson, Al, Deng, Qiqi, Alberts, Steven R., Andre, Thierry, Wolmark, Norman, Grothey, Axel, Sargent, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2010
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815708/
https://ncbi.nlm.nih.gov/pubmed/20008641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.1407
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia